mgta-145
Showing 1 - 2 of 2
Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)
Completed
- Multiple Myeloma
- MGTA-145
- Plerixafor
-
Stanford, CaliforniaStanford University
Aug 17, 2022